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investigating altered brain 
development in infants 
with congenital heart disease using 
tensor‑based morphometry
isabel H. X. ng1, Alexandra f. Bonthrone1, christopher J. Kelly1, Lucilio cordero‑Grande1,2, 
emer J. Hughes1, Anthony n. price1, Jana Hutter1, Suresh Victor1, Andreas Schuh3, 
Daniel Rueckert3, Joseph V. Hajnal1,4, John Simpson5, A. David edwards1, 
Mary A. Rutherford1, Dafnis Batalle1,6 & Serena J. counsell1*
Magnetic resonance (MR) imaging studies have demonstrated reduced global and regional brain 
volumes in infants with congenital heart disease (cHD). this study aimed to provide a more detailed 
evaluation of altered structural brain development in newborn infants with cHD compared to healthy 
controls using tensor-based morphometry (TBM). We compared brain development in 64 infants 
with CHD to 192 age- and sex-matched healthy controls. T2-weighted MR images obtained prior to 
surgery were analysed to compare voxel-wise differences in structure across the whole brain between 
groups. cerebral oxygen delivery  (cDo2) was measured in infants with CHD (n = 49) using phase 
contrast MR imaging and the relationship between  cDo2 and voxel‑wise brain structure was assessed 
using TBM. After correcting for global scaling differences, clusters of significant volume reduction in 
infants with cHD were demonstrated bilaterally within the basal ganglia, thalami, corpus callosum, 
occipital, temporal, parietal and frontal lobes, and right hippocampus (p < 0.025 after family-wise 
error correction). Clusters of significant volume expansion in infants with CHD were identified in 
cerebrospinal fluid spaces (p < 0.025). After correcting for global brain size, there was no significant 
association between voxel‑wise brain structure and  cDo2. This study localizes abnormal brain 
development in infants with cHD, identifying areas of particular vulnerability.
Congenital heart disease (CHD) is the most common congenital abnormality, with a reported prevalence of 
over 9 per 1,000 live births  worldwide1. As advances in management of CHD lead to improved mortality  rates2, 
morbidity and long-term outcomes have become of increasing concern. Infants and children with CHD may 
have impaired neurodevelopmental outcomes compared to healthy peers, even in the absence of known genetic 
 syndromes3–10. Impaired neurodevelopment in CHD leads not only to short-term impact on early childhood 
development, but also long-term impact, including poorer school performance and academic achievement, and 
an increased need for special education  services11–14.
The neurodevelopmental abnormalities observed in survivors of CHD may be related to abnormal brain 
development. Magnetic resonance (MR) imaging studies have identified brain injury and abnormal brain devel-
opment in infants with CHD including impaired cortical folding and white and grey matter microstructural 
 abnormalities15–26. In addition, foetuses and infants with CHD have impaired brain growth, including reductions 
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in total and regional brain volumes, compared to healthy  controls22–34. These abnormalities are evident prior to 
surgery and have been associated with reduced cerebral oxygen  delivery24,25,33.
Tensor-based morphometry (TBM) is an MR analysis approach that enables the comparison of variation 
in shape and volume between the brains of individuals on a voxel-wise basis across the whole  brain35,36. This 
method enables increased precision in localizing structural variation between groups compared to methods that 
involve segmentation of pre-selected brain  regions37. Of note, TBM is able to identify structural differences that 
are independent of global scaling differences, ensuring observed differences do not merely reflect differences in 
global brain volume and head size.
The primary aim of this study was to assess differences in brain structure between infants with CHD and 
healthy controls using TBM in order to identify those areas at risk of abnormal development in infants with 
CHD. Our secondary aim was to assess the relationship between structural brain development at a voxel-wise 
level and cerebral oxygen delivery  (CDO2) in infants with CHD.
Results
Demographics. We studied 64 infants with CHD (35 male) and 192 healthy controls (105 male). There were 
no significant differences in gestational age (GA) at birth, post-menstrual age (PMA) at scan, sex, birthweight, 
head circumference at birth, head circumference at scan, or mode of delivery between infants with CHD and 
healthy controls (Table 1).
Of the 64 infants with CHD, white matter injury was identified in 19 infants and cerebellar haemorrhage 
was identified in 4 infants on MR imaging (Supplementary Table S1). Sixty of the 64 infants were diagnosed 
with CHD antenatally.
tensor‑based morphometry. CHD versus healthy controls. After factoring out global scaling differenc-
es, infants with CHD had clusters of significantly reduced volumes within the deep grey matter, corpus callosum, 
temporal, parietal, occipital and frontal lobes, compared to controls (Fig. 1a). Specifically, significant reductions 
in volume were identified bilaterally in the caudate nuclei, globus pallidi and anterior and medial thalami; in the 
right hippocampus; in the isthmus and splenium of the corpus callosum; the posterior cingulate gyri; within the 
frontal lobes bilaterally; the postcentral gyri; the medial occipital lobes, around the calcarine fissures and along 
the optic radiations; bilaterally within the middle and posterior parts of the superior temporal gyri and in the 
posterior part of the medial and inferior temporal gyri.
There were clusters of significantly expanded volumes in cerebrospinal fluid (CSF) spaces compared to con-
trols (Fig. 1b). Significantly expanded volumes were identified within the cisterna magna, cisterna pontis, and 
Table 1.  Demographic details of infants with congenital heart disease (CHD) and healthy controls. Values 
shown are median (range), except where indicated. *Student’s t-test used. † Mann–Whitney U test used. # Chi-
squared test used.
Variable Infants with CHD (n = 64) Healthy controls (n = 192) p-value
Gestational age at birth, weeks 38.57 (35.29–41.57) 38.86 (35.14–40.43) 0.06†
Post-menstrual age at scan, weeks 39.29 (36.43–42.29) 39.43 (36.43–42.86) 0.23†
Male, no. (%) 35 (55) 105 (55) 1.00#
Birth weight, kg 3.11 (1.81–4.29) 3.11 (1.87–4.80) 0.37*
Birth weight z-score − 0.83 (− 4.32 to 1.58) − 0.65 (− 3.57 to 3.12) 0.23*
Birth head circumference, cm 33.70 (29.00–38.50) 34.00 (30.00–37.00) 0.48†
Birth head circumference z-score − 0.60 (− 4.92 to 3.09) − 0.27 (− 3.96 to 2.75) 0.24†
Head circumference at scan, cm 34.00 (29.50–37.40) 34.00 (28.50–37.50) 0.35†
Head circumference at scan z-score − 0.81 (− 4.60 to 2.15) − 0.48 (− 5.61 to 2.70) 0.30†
Mode of delivery, no. (%)
Spontaneous/induced vaginal delivery 24 (38) 58 (30)
0.07#
Instrumental delivery 11 (17) 38 (20)
Elective C-section 7 (11) 48 (25)
Emergency C-section 22 (34) 48 (25)
Cardiac diagnosis, no. (%)
Transposition of the great arteries 29 (45) – –
Coarctation of the aorta 15 (23) – –
Hypoplastic left heart syndrome 3 (5) – –
Pulmonary atresia 2 (3) – –
Tricuspid atresia 2 (3) – –
Tetralogy of Fallot 7 (11) – –
Pulmonary stenosis 4 (6) – –
Truncus arteriosus 1 (2) – –
Large ventricular septal defect 1 (2) – –
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interpenduncular cistern, as well as bilaterally in the ambient cisterns, and extra-axial spaces around the sylvian 
fissures, frontal lobes, parietal lobes and inferior poles of the temporal lobes. Symmetrical clusters of significant 
expansions were also found in the third ventricle, fourth ventricle and in the caudothalamic notches bilaterally.
Figure 1.  Map of t-statistic values of areas of significant (a) reductions and (b) expansions in volumes in infants 
with congenital heart disease compared to healthy controls (family-wise-error-corrected p < 0.025). Images 
in 3 planes are shown: (i) axial, (ii) sagittal, (iii) coronal. t-statistic range is shown on the colour bars. Results 
are overlaid on the template image with post-menstrual age at scan of 40 weeks. Left–right orientation follows 
radiological convention. Sagittal views are presented from right to left.
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On comparison of total brain and regional brain volumes, we found that infants with CHD had significantly 
smaller total brain, cortical grey matter, white matter, deep grey matter, and cerebellum volumes than controls 
(Supplementary Table S2). There was no significant difference in relative regional volumes between groups (Sup-
plementary Table S2). The results of subgroup analysis of abnormal mixing cardiac lesions (n = 31), left-sided 
cardiac lesions (n = 18), and right-sided cardiac lesions (n = 15) compared to matched controls are included in 
Supplementary Figure S1.
Brain development and cerebral oxygen delivery. Forty-nine infants with CHD underwent phase contrast 
flow imaging and cerebral blood flow (CBF) was measured and used to calculate  CDO2. The median CBF was 
84.58 mL/min with range 45.58–123.16 mL/min and the median  CDO2 was 1657  mLO2/min with range 1,106–
3,023  mLO2/min. There were no significant differences between infants in whom  CDO2 was measured, and 
those in whom  CDO2 was not (Supplementary Table S3). No significant association between voxel-wise brain 
structure and  CDO2 or CBF was found on TBM analysis.
There were no significant differences in CBF or  CDO2 between cardiac subgroups (Supplementary Figure S2). 
A significant positive correlation was observed between  CDO2 and total brain, cortical grey matter, and deep 
grey matter volumes (Supplementary Table S4).
Discussion
This study identified regions of abnormal brain development on preoperative MR imaging in infants with CHD 
compared to healthy age- and sex-matched controls after taking into account differences in overall brain size 
between groups. However, after accounting for global scaling, we did not identify any significant associations 
between  CDO2 and structural brain development at a voxel-wise level.
Previous studies have shown reductions in total brain volume, regional brain  volumes23–29 and biometric 
measurements of brain  size30,31, and expansions in extra-axial CSF  volume24 in infants with CHD prior to sur-
gery. Similar to our previous reports in a subsample of this cohort, we observed smaller total brain, white mat-
ter, deep grey matter and regional cortical grey matter volumes in infants with CHD compared to  controls24,25. 
However, we did not observe any significant differences in relative regional volumes between infants with CHD 
and controls, suggesting similar volume reductions across all brain regions at this coarse level of analysis. Our 
study used TBM to extend these analyses in order to identify specific locations of altered brain development in 
infants with CHD, taking into account global size differences, without the need for a priori definition of regions 
of interest or image segmentation.
In the analysis of different CHD subgroups, we observed different patterns of abnormal brain development in 
infants with different cardiac physiologies. However, there were no significant differences in measures of cerebral 
haemodynamics between cardiac subgroups. It is not clear whether the smaller regions of volume differences in 
the left- and right-sided lesion groups compared to controls are due to cardiac physiology or the small sample 
sizes of these 2 groups.
Assessing brain development may be useful in understanding the basis of impaired long-term neurodevelop-
ment in survivors of CHD. Previous studies have demonstrated significant associations between brain volume and 
impaired neurodevelopment in this high-risk group. Reduced subcortical grey matter and increased CSF volumes 
in the neonatal period are associated with impaired behavioural state regulation and visual orienting in infants 
with CHD prior to  surgery10. In addition, smaller cortical grey matter, white matter,  cerebellar28, basal ganglia 
and thalami, and  brainstem38 volumes in newborns with CHD after surgery are associated with poorer cognitive 
and language outcome  scores28 and below-average  IQ38 in later  infancy28 and  childhood38. These relationships 
persist into adolescence where reduced white matter,  cerebellar39, and hippocampal  volumes39,40 are associated 
with impaired total IQ and other measures of cognitive, motor and executive  functions39,40.
In this study, we identified significant clusters of reduced volume in regions that are important for cogni-
tive, behavioural and motor function including the caudate nuclei, globus pallidi, thalami, posterior cingulate 
gyri, frontal lobes, and the hippocampus. The basal ganglia and thalami are associated with cognitive, affective, 
somatosensory and motor  function41,42 and reductions in volume within the thalami and basal ganglia have been 
linked to adverse neurodevelopment in  CHD38 and  prematurity43,44. In particular, the anterior thalami, where we 
localized volume reduction, have been associated with information processing and  attention42,  memory42,45 and 
spatial  navigation45. The hippocampi play a crucial role in intellectual function and  memory46–48 and significant 
correlations have been observed between hippocampal volume and working  memory40, verbal  comprehension40, 
perceptual  reasoning39 and total IQ in adolescents with  CHD39,40. In addition, we localized volume reductions 
to the posterior cingulate gyri, regions which are linked to  memory49,50, emotional  response51,  attention52 and 
spatial  orientation49. We also observed clusters of significant reductions in the frontal lobes. The frontal lobes 
are associated with many higher cognitive functions, including attention, executive function, impulse control, 
language, and  memory53, functions which may be impaired in children with  CHD54–56.
We localized significant volume expansions in CSF spaces, including the basal cisterns, third and fourth 
ventricles and caudothalamic notches bilaterally. Increased CSF volume has been found in children with spe-
cific language impairment compared to  controls57 and has been linked to autism spectrum disorder in infants 
at high genetic  risk58, and to moderate-severe neurodevelopmental  disability59 and decreased working memory 
 performance60 in preterm infants.
There are a number of potential mechanisms underlying abnormal brain development in infants with CHD 
including altered cerebral  haemodynamics24,61–63, reduced substrate delivery to the  brain64, genetic  factors65–67 
and impaired placental  development68,69. We previously reported a correlation between  CDO2 and preoperative 
neonatal total brain and cortical grey matter volumes in our CHD  cohort24. In this study, we also observed sig-
nificant associations between  CDO2 and total brain, cortical grey matter, and deep grey matter volumes. However, 
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after controlling for global scaling, we did not identify additional clusters of altered development on a voxel-wise 
level associated with  CDO2. This suggests that either (i) reduced  CDO2 impairs growth across the whole brain 
and there are no regions that are specifically vulnerable to low  CDO2 or (ii) there was insufficient statistical power 
to assess voxel-wise differences after correcting for multiple comparisons. Of note, the measurement of  CDO2 
at a single postnatal timepoint may not reflect the full burden of hypoxia experienced by these infants. Indeed, 
reduced cerebral oxygenation has been associated with reduced brain volume in  utero33. While the reduction 
of  CDO2 is probably global, intrinsic vulnerabilities, such as high metabolic demand, could play a role in the 
impact on specific brain structures. In other at-risk populations of neonates, such as in those experiencing acute 
hypoxic-ischaemic events, patterns of injury involving structures with higher metabolic demand, including the 
basal ganglia and thalami, and hippocampus, have been  observed70,71.
However, in this study, we observed clusters of volume reductions, in regions including both the grey and 
white matter. This is presumably because the effect of chronic hypoxia differs from that of acute events, and dif-
ferent regions of the brain have varying metabolic demands at different stages of  development72,73. Furthermore, 
cerebral autoregulatory mechanisms play an important  role61, and different regions of the brain may be affected 
by different degrees of “brain sparing”74, particularly as the cerebral vasculature is itself developing during mid-
late  gestation75.
A limitation of this study is that, as yet, we do not have neurodevelopmental outcome data for all of the infants. 
Further studies are required to examine the relationship between regions of altered brain development identified 
on voxel-wise analyses and neurodevelopmental outcome.
conclusions
Using tensor-based morphometry, this study identified clusters of localized volume alterations in regions impor-
tant for subsequent cognitive, behavioural and motor function in infants with CHD compared to healthy control 
infants. Whilst cerebral oxygen delivery was significantly associated with total brain and regional brain volumes, 
no significant relationship was found between cerebral oxygen delivery and voxel-wise brain volume after con-
trolling for global size differences. Assessing brain structural abnormalities using a voxel-wise approach, such 
as tensor-based morphometry, refines our understanding of abnormal brain development in infants with CHD.
Methods
The project was approved by the National Research Ethics Service West London committee (CHD: 07/H0707/105; 
Controls: 14/LO/1169). Informed written parental consent was obtained before imaging. All methods and experi-
ments were carried out in compliance with relevant guidelines and regulations.
participants. A prospective cohort of 74 infants born with critical or serious CHD requiring surgery within 
one year, based on previously published UK  classification76,77, was recruited for MR neuroimaging from the Neo-
natal Intensive Care Unit at St Thomas’ Hospital, London. Exclusion criteria were known or suspected genetic 
syndromes, major abnormalities on MR imaging and GA at birth < 35 weeks. Sixty-four infants were included in 
the analysis (Fig. 2). Healthy controls were obtained from the Developing Human Connectome Project (dHCP) 
 database78 and were matched for GA at birth, PMA at scan, and sex, to each infant in the CHD group in a ratio 
of three healthy controls per one infant with CHD. Matching of healthy controls to infants with CHD was car-
ried out in R, version 3.2.379, using an automated method based on the daisy dissimilarity matrix  calculation25,80.
MR imaging. High-resolution MR imaging was performed on a Philips Achieva 3-T system (Best, The Neth-
erlands) using a 32-channel neonatal head coil and neonatal positioning  device81. T2-weighted, T1-weighted, and 
diffusion-weighted MR images were acquired using the dHCP protocol optimized for neonatal  scanning78,81,82. 
Phase contrast flow imaging was also acquired for the CHD  cases24.
T2-weighted images were used for TBM analysis and were acquired using a multi-slice turbo spin echo 
sequence in 2 stacks of 2-dimensional slices in sagittal and axial planes, with pulse repetition time 12 s, echo time 
156 ms, flip angle 90°, slice thickness 1.6 mm with 0.8 mm overlap, in-plane resolution 0.8 mm × 0.8 mm. Quan-
titative flow imaging was acquired using velocity-sensitized phase contrast imaging, with a single-slice spoiled 
gradient echo sequence, with field of view 100 mm × 100 mm, acquisition resolution 0.6 mm × 0.6 mm × 4.0 mm, 
repetition time 6.4 ms, echo time 4.3 ms, flip angle 10°, 20 cardiac phases, maximal encoding velocity 140 cm/s, 
and scan time 71 s83. Other imaging parameters have been previously  described25. Infants were scanned in natural 
sleep without sedation, in the presence of a paediatrician experienced in MR imaging procedures. All images 
were reviewed for abnormalities by a paediatric neuroradiologist.
Infants had physiological monitoring (electrocardiography, respiratory rate, oxygen saturations and tempera-
ture) throughout the scan. Ear protection was used to minimize impact of scanner noise: ear plugs moulded 
from putty (President Putty, Coltene Whaledent, Mahwah, NJ, USA) placed in the external auditory meatus and 
covered with neonatal earmuffs (MiniMuffs, Natus Medical Inc., San Carlos, CA, USA), with an acoustic foam 
hood for noise absorption positioned over the infant in the scanner.
Structural image processing. Motion-correction and slice-to-volume image reconstruction were carried 
out retrospectively using a dedicated algorithm to obtain 0.8  mm3 isotropic T2-weighted  images84,85. These were 
segmented into tissue type (white matter, grey matter, cerebrospinal fluid (CSF), cerebellum, deep grey matter) 
using a multi-structure expectation–maximization-based segmentation technique in a neonatal-specific auto-
mated pipeline described  previously86–88.
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cerebral oxygen delivery. For infants with CHD, cerebral blood flow (CBF) was calculated from phase 
contrast MR imaging acquired in a plane perpendicular to both internal carotids and basilar arteries at the level 
of the sphenoid bone, using a previously described  method24,83. Haemoglobin (Hb) measurements were per-
formed as part of routine clinical care, at a median (range) of 2 (− 1 to 10) days before the scan. Arterial oxygen 
saturation  (SaO2) was measured at the time of scan using a Masimo Radical-7 monitor (Masimo Corp, Irvine, 
CA) applied to the right hand. Cerebral oxygen delivery  (CDO2) was calculated using the following  formula89:
where 1.36 is the amount of oxygen bound per gram of haemoglobin at 1 atmosphere (Hüfner’s constant)29.
tensor‑based morphometry. Neonatal templates constructed for each week of gestation created from 
the dHCP neuroimaging database were used as templates for  registration90. Subject T2-weighted images were 
registered to an age-at-scan-matched template image using the Symmetric Normalization (SyN) algorithm from 




× 1.36× [CBF] (mL/min)
Figure 2.  Flowchart showing number of cases excluded from further analysis.
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Advanced Normalization Tools (ANTs), version 3.091. Segmented T2-weighted images were included in the 
algorithm to improve the quality of registration.
Following rigid and affine transformations of the image, the non-linear transformations from the SyN algo-
rithm were used to create deformation tensor fields within the template space. By using only non-linear transfor-
mations, global volume differences are factored out. The resulting tensor fields describing the voxel-wise shape 
and volume change from the template to each subject image were used to calculate scalar Jacobian determinants, 
which were subject to logarithm transformation, using  ANTs92.
Log-Jacobian determinant maps were smoothed with a sigma of 3.5 mm full width at half maximum Gaussian 
filter. To facilitate processing, the log-Jacobian determinant maps were re-sized to a voxel size of 1  mm3 isotropic 
prior to statistical analysis.
Statistical analysis. Clinical data were compared between groups using Student’s t-test or Mann–Whitney 
U for continuous variables, with prior normality testing using the Shapiro–Wilk test. Chi-squared test was used 
for categorical variables. A p-value of less than 0.05 was taken as significant. Missing values for clinical data were 
dealt with through pairwise deletion. Statistical analysis was performed with IBM SPSS Statistics for Windows, 
version 24 (IBM Corp., Armonk, N.Y., USA). Z-scores for birth weight and head circumference were calcu-
lated using the  GrowthChartsUK-WHO application, version 2.0.193, based on UK-WHO 2006 population reference 
 data94.
For TBM analysis, the 64 infants with CHD were first compared to age- and sex-matched healthy controls. 
Voxel-wise t-tests of log-Jacobian determinants between CHD and control groups were carried out using FSL 
Randomise (FSL, version 6.01)95,96. Threshold-free cluster enhancement was used with a random permutation 
method with 10 000 permutations, based on a General Linear Model (GLM)  matrix95,97. Additionally, for CHD 
infants with successful phase contrast flow imaging (n = 49), voxel-wise regression analyses of log-Jacobian deter-
minants with  CDO2 and CBF were performed. A brain mask for the template image at a PMA of 40-weeks was 
used in all analyses to include only brain tissue and CSF in the  comparisons90. GA at birth and sex were included 
as nuisance variables in each model. P-values were corrected for multiple comparisons. A family-wise-error-
corrected p-value of less than 0.025 was considered significant, to account for testing differences in two directions 
(i.e. CHD > controls and CHD < controls, or in the case of  CDO2, a positive and negative correlation with  CDO2).
Further supplementary methods are included within the supplementary information.
Data availability
Anonymised data pertaining to the Developing Human Connectome Project have been made publicly available 
at the Developing Human Connectome Project repository and can be accessed at https ://www.devel oping conne 
ctome .org/. The remaining data, analytic methods, and study materials will be available to other researchers for 
the purposes of reproducing the results or replicating the procedure on reasonable request.
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